Fatty acid treatment for ectopic calcium deposition
AssigneeScotia Holdings PLC
InventorsDavid F. Horrobin, Brenda E. Reynolds
Life of this patent
Estimating the term…
Abstract
Prevention and/or treatment of abnormal calcification in any tissue by the administration of (i) GLA and/or its EFA metabolites, and in particular the rapidly produced DGLA and/or (ii) EPA and/or its precursors, stearidonic acid and 20:4 n-3, and metabolites, docosahexaenoic acid (DHA) or docosapenmenoic acid (22:5 n-3), as such or in salt or other pharmacologically acceptable form. This is especially suitable for prevention or treatment of nephrocalcinosis and/or renal stones.
Claims5
A method of treating or preventing ectopic calcium deposition in soft tissue of blood vessels, cornea, conjunctivae, skin and brain in humans or animal in need thereof by administering one or more essential fatty acids of the n-6 and n-3 series selected from the group consisting of gamma-linolenic acid, dihomo-gamma-linolenic acid, arachidonic acid, adrenic acid, 22:5 delta-4,7,10,13,16, stearidonic acid, 20:4 delta-8,11,14,17, eicosapentaenoic acid, 22:5 delta-7,10,13,16,19 and docosahexaenoic acid, wherein the essential fatty acids are administered as such or in salt or other pharmacologically acceptable form.
Dependencies are inferred from the claim text.